We are live on ! Find out more
ASXC

Asensus Surgical, Inc.

Delisted

ASXC was delisted on the 21st of August, 2024.

91 hedge funds and large institutions have $12.4M invested in Asensus Surgical, Inc. in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

21% less funds holding

Funds holding: 11591 (-24)

33% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 24

58% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 40

65% less capital invested

Capital invested by funds: $35.9M → $12.4M (-$23.5M)

74% less call options, than puts

Call options by funds: $249K | Put options by funds: $961K

Holders
91
Holders Change
-24
Holders Change %
-20.87%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
17
Increased
16
Reduced
24
Closed
40
Calls
$249K
Puts
$961K
Net Calls
-$712K
Net Calls Change
-$563K
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$4.32M +$319K +715,839 +7%
Millennium Management
2
Millennium Management
New York
$2.01M +$2.19M +4,902,823 +3,552%
BlackRock
3
BlackRock
New York
$1.47M -$5.24M -11,749,109 -76%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$870K -$686K -1,537,226 -41%
E
5
Ergoteles
New York
$416K +$440K +985,763 +1,697%
Susquehanna International Group
6
Susquehanna International Group
Pennsylvania
$387K +$57.7K +129,349 +15%
State Street
7
State Street
Massachusetts
$325K -$2.77M -6,208,426 -88%
Morgan Stanley
8
Morgan Stanley
New York
$261K -$475K -1,064,156 -62%
SHI
9
SV Health Investors
Massachusetts
$203K
Citadel Advisors
10
Citadel Advisors
Florida
$184K -$550K -1,232,974 -73%
UBS Group
11
UBS Group
Switzerland
$167K +$68.1K +152,606 +57%
Northern Trust
12
Northern Trust
Illinois
$165K -$688K -1,542,083 -79%
GCP
13
GSA Capital Partners
United Kingdom
$148K +$67.4K +151,068 +68%
Renaissance Technologies
14
Renaissance Technologies
New York
$132K -$472K -1,057,138 -76%
Deutsche Bank
15
Deutsche Bank
Germany
$115K -$56.7K -127,164 -31%
AQR Capital Management
16
AQR Capital Management
Connecticut
$106K +$119K +265,963 New
Qube Research & Technologies (QRT)
17
Qube Research & Technologies (QRT)
United Kingdom
$87K +$98K +219,542 New
T. Rowe Price Associates
18
T. Rowe Price Associates
Maryland
$83K -$9.48K -21,241 -9%
HF
19
HRT Financial
New York
$80K +$34.1K +76,421 +60%
CM
20
Caption Management
Oklahoma
$80K +$89.8K +201,243 New
IA
21
IFP Advisors
Florida
$79K
Osaic Holdings
22
Osaic Holdings
Arizona
$76K -$39.6K -88,749 -32%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$49K -$303K -679,972 -85%
Goldman Sachs
24
Goldman Sachs
New York
$49K -$38.9K -87,275 -41%
LPL Financial
25
LPL Financial
California
$42K +$4.46K +10,000 +10%

ASXC Hedge Fund Activity: Q2 2022 in Review

91 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Asensus Surgical, Inc. (ASXC) for Q2 2022, worth a combined $12.4M — down 65% from $35.9M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ASXC and 17 opened new positions — a net loss of 23 holders — while 24 trimmed existing stakes and 16 added.

The largest buyer was Millennium Management, adding an estimated $2.19M. The largest seller was BlackRock, cutting an estimated $5.24M.

  • 91 institutional investors held Asensus Surgical, Inc. (ASXC) as of Q2 2022, down from 115 in Q1 2022.
  • Funds reported $12.4M of Asensus Surgical, Inc. stock for Q2 2022, down 65% quarter-over-quarter.
  • 17 funds opened new Asensus Surgical, Inc. positions in Q2 2022 and 40 closed out, a net change of -23 holders.
  • The largest Asensus Surgical, Inc. buyer in Q2 2022 was Millennium Management, an estimated $2.19M added.
  • The largest Asensus Surgical, Inc. seller in Q2 2022 was BlackRock, an estimated $5.24M sold.

Based on aggregated 13F filings for Q2 2022.